Jump to main content
Jump to site search


Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype

Author affiliations

Abstract

Staphylococcus aureus (S. aureus) is an asymptomatic colonizer of 30% of all human beings. While generally benign, antibiotic resistance contributes to the success of S. aureus as a human pathogen. Resistance is rapidly evolved through a wide portfolio of mechanisms including horizontal gene transfer and chromosomal mutation. In addition to traditional resistance mechanisms, a special feature of S. aureus pathogenesis is its ability to survive on both biotic and abiotic surfaces in the biofilm state. Due to this characteristic, S. aureus is a leading cause of human infection. Methicillin-resistant S. aureus (MRSA) in particular has emerged as a widespread cause of both community- and hospital-acquired infections. Currently, MRSA is responsible for 10-fold more infections than all multi-drug resistant (MDR) Gram-negative pathogens combined. Recently, MRSA was classified by the World Health Organization (WHO) as one of twelve priority pathogens that threaten human health. In this targeted mini-review, we discuss MRSA biofilm production, the relationship of biofilm production to antibiotic resistance, and front-line techniques to defeat the biofilm-resistance system.

Graphical abstract: Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype

Back to tab navigation

Publication details

The article was received on 26 Jan 2019, accepted on 12 Mar 2019 and first published on 14 Mar 2019


Article type: Review Article
DOI: 10.1039/C9MD00044E
Citation: Med. Chem. Commun., 2019, Advance Article

  •   Request permissions

    Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype

    K. M. Craft, J. M. Nguyen, L. J. Berg and S. D. Townsend, Med. Chem. Commun., 2019, Advance Article , DOI: 10.1039/C9MD00044E

Search articles by author

Spotlight

Advertisements